Owing to the expression of estrogen receptor (ER) in ~75% of patients with BC and the stimulation of tumor growth by estrogen, one of the current treatment strategies for ER+ BC is to reduce the concentration of estrogen, also known as endocrine therapy. The gene discussed is ESR1; the disease is neoplasm.